Product Description

Rift Valley fever phlebovirus Nucleocapsid Protein Polyclonal Antibody

Sizes: 50μl, 100μl

Catalogue Numbers: NCP0154P-50, NCP0154P-100

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Background: Rift Valley fever (RVF) is a mosquito-borne viral zoonosis that was first discovered in Kenya in 1930 and is now endemic throughout mμltiple African countries and the Arabian Peninsμla. RVF virus primarily infects domestic livestock (sheep, goats, cattle) causing high rates of neonatal mortality and abortion, with human infection resμlting in a wide variety of clinical outcomes, ranging from self-limiting febrile illness to life-threatening haemorrhagic diatheses, and miscarriage in pregnant women. Since its discovery, RVF has caused many outbreaks in Africa and the Arabian Peninsμla with major impacts on human and animal health. However, options for the control of RVF outbreaks are limited by the lack of licensed human vaccines or therapeutics.

Category: Primary Antibody

Reactivity: RVFV-NP

Host: Rabbit

Applications: WB, ELISA

Clonality: Polyclonal

Conjugate: Unconjugated

Modification: Unmodification

Immunogen: Recombinant protein of RVFV-NP.

Dilution: WB: 1:500~1:2000
ELISA: 1:5000~10000

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Specificity: Rift Valley fever phlebovirus Nucleocapsid Protein polyclonal antibody detects endogenous levels of RVFV-NP protein.

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

SwissProt: DQ380154.1

Product: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.

Research Use Only